Chemotherapy Combined with Immunotherapy and Targeted Therapy in Cholangiocarcinoma

NCT06718257 · clinicaltrials.gov ↗

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Cholangiocarcinoma

Interventions

DRUG: Gemcitabine combined with cisplatin or oxaliplatin
DRUG: Gemcitabine combined with cisplatin or oxaliplatin, PD-1/L1 and TKI inhibitors

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University